Advanced imaging in surveillance of Barrett’s esophagus: Is the juice worth the squeeze?  

作　　者：Sara A Cerrone Arvind J Trindade 

机构地区：[1]Division of Gastroenterology,Long Island Jewish Medical Center,Zucker School of Medicine at Hofstra/Northwell,Northwell Health System

出　　处：《World Journal of Gastroenterology》2019年第25期3108-3115,共8页世界胃肠病学杂志（英文版）

摘　　要：Esophageal cancer is on the rise.The known precursor lesion is Barrett’s esophagus(BE).Patients with dysplasia are at higher risk of developing esophageal cancer.Currently the gold standard for surveillance endoscopy involves taking targeted biopsies of abnormal areas as well as random biopsies every 1-2 cm of the length of the Barrett’s.Unfortunately studies have shown that this surveillance can miss dysplasia and cancer.Advanced imaging technologies have been developed that may help detect dysplasia in BE.This opinion review discusses advanced imaging in BE surveillance endoscopy and its utility in clinical practice.Esophageal cancer is on the rise. The known precursor lesion is Barrett’s esophagus(BE). Patients with dysplasia are at higher risk of developing esophageal cancer. Currently the gold standard for surveillance endoscopy involves taking targeted biopsies of abnormal areas as well as random biopsies every 1-2 cm of the length of the Barrett’s. Unfortunately studies have shown that this surveillance can miss dysplasia and cancer. Advanced imaging technologies have been developed that may help detect dysplasia in BE. This opinion review discusses advanced imaging in BE surveillance endoscopy and its utility in clinical practice.

关 键 词：Barrett’s ESOPHAGUS Advanced imaging CHROMOENDOSCOPY ENDOMICROSCOPY 

分 类 号：R735.1[医药卫生—肿瘤]